Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Persistent high levels of carcinoembryonic antigen after tumor resection are associated with poorer survival outcomes in patients with resected colon cancer.
Muñoz-Montaño WR, López-Basave HN, Castillo-Morales A, Castillo-Morales C, Sánchez-Trejo K, Catalán R, Díaz-Romero C, Lino-Silva LS, Maliachi-Díaz A, Ruiz-García E, Herrera-Martínez M, Calderillo-Ruíz G. Muñoz-Montaño WR, et al. BMC Cancer. 2023 Jul 19;23(1):678. doi: 10.1186/s12885-023-11126-4. BMC Cancer. 2023. PMID: 37468881 Free PMC article.
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.
Arrieta O, Muñoz-Montaño W, Muñiz-Hernández S, Campos S, Catalán R, Soto-Molina H, Guzmán Vázquez S, Díaz-Álvarez O, Martínez-Pacheco V, Turcott JG, Ramos-Ramírez M, Cabrera-Miranda L, Barrón F, Cardona AF. Arrieta O, et al. Front Oncol. 2021 Apr 20;11:641975. doi: 10.3389/fonc.2021.641975. eCollection 2021. Front Oncol. 2021. PMID: 33959504 Free PMC article.
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin.
Muñoz-Montaño W, Muñiz-Hernández S, Avilés-Salas A, Catalán R, Lara-Mejía L, Samtani-Bassarmal S, Cardona AF, Mendoza-Desión J, Hernández-Cueto D, Maldonado A, Baay-Guzmán G, Huerta-Yepes S, Arrieta O. Muñoz-Montaño W, et al. BMC Cancer. 2021 Aug 5;21(1):892. doi: 10.1186/s12885-021-08287-5. BMC Cancer. 2021. PMID: 34353292 Free PMC article.
The Prognostic Significance of HALP Index for Colon Cancer Patients in a Hispanic-Based Population.
Calderillo Ruiz G, Lopez Basave H, Vazquez Renteria RS, Castillo Morales A, Guijosa A, Castillo Morales C, Herrera M, Diaz C, Vazquez Cortes E, Ruiz-Garcia E, Munoz Montano WR. Calderillo Ruiz G, et al. Among authors: munoz montano wr. J Oncol. 2022 Nov 23;2022:4324635. doi: 10.1155/2022/4324635. eCollection 2022. J Oncol. 2022. PMID: 36467502 Free PMC article.
Impact of ileostomy in the adjuvant treatment and outcome of colon cancer.
Calderillo-Ruíz G, López-Basave HN, Muñoz-Montaño WR, Díaz-Romero MC, Carbajal-López B, Castillo-Morales C, Pérez-Yépez EA, Albarran-García A. Calderillo-Ruíz G, et al. Among authors: munoz montano wr. Int J Colorectal Dis. 2023 Jun 1;38(1):158. doi: 10.1007/s00384-023-04421-w. Int J Colorectal Dis. 2023. PMID: 37261538
A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.
Arrieta O, López-Macías D, Mendoza-García VO, Bacon-Fonseca L, Muñoz-Montaño W, Macedo-Pérez EO, Muñiz-Hernández S, Blake-Cerda M, Corona-Cruz JF. Arrieta O, et al. Cancer Chemother Pharmacol. 2014 May;73(5):975-82. doi: 10.1007/s00280-014-2429-5. Epub 2014 Apr 1. Cancer Chemother Pharmacol. 2014. PMID: 24687408 Clinical Trial.
Radiation-induced lung injury: current evidence.
Arroyo-Hernández M, Maldonado F, Lozano-Ruiz F, Muñoz-Montaño W, Nuñez-Baez M, Arrieta O. Arroyo-Hernández M, et al. BMC Pulm Med. 2021 Jan 6;21(1):9. doi: 10.1186/s12890-020-01376-4. BMC Pulm Med. 2021. PMID: 33407290 Free PMC article. Review.
Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case-control study.
Muñoz-Montaño WR, Cabrera-Galeana P, De la Garza-Ramos C, Azim HA Jr, Tabares A, Perez V, Porras Reyes F, Sanchez Benitez D, Alvarado-Miranda A, Lara-Medina F, Vazquez Romo R, Bargallo-Rocha E, Arrieta O, Villarreal-Garza C. Muñoz-Montaño WR, et al. Breast Cancer Res Treat. 2021 Jul;188(2):489-500. doi: 10.1007/s10549-021-06225-4. Epub 2021 Jun 16. Breast Cancer Res Treat. 2021. PMID: 34132938
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer.
Alvarado-Miranda A, Lara-Medina FU, Muñoz-Montaño WR, Zinser-Sierra JW, Galeana PAC, Garza CV, Sanchez Benitez D, Limón Rodríguez JA, Arce Salinas CH, Guijosa A, Arrieta O. Alvarado-Miranda A, et al. Among authors: munoz montano wr. Curr Oncol. 2023 Jun 24;30(7):6097-6110. doi: 10.3390/curroncol30070454. Curr Oncol. 2023. PMID: 37504314 Free PMC article.
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment.
Muñoz-Montaño W, Cabrera-Galeana P, Alvarado-Miranda A, Villarreal-Garza C, Mohar A, Olvera A, Bargallo-Rocha E, Lara-Medina F, Arrieta O. Muñoz-Montaño W, et al. Clin Breast Cancer. 2020 Aug;20(4):307-316.e1. doi: 10.1016/j.clbc.2019.12.011. Epub 2020 Jan 21. Clin Breast Cancer. 2020. PMID: 32305297
18 results